Professor Moji Adeyeye, Director General of NAFDAC, explains why falsified medicines pose such a threat to patients worldwide and why a strong judiciary is necessary to help deal with the issue.
This interview was recorded at our ‘Pathways to Safe Medicines‘ dialogue, which aimed to generate renewed focus and consensus around health commodity traceability as a realistic and high return on investment intervention for addressing health supply chain integrity.